Resources

From the FDA: AI in drug development is now operational, and must be designed with rigor, transparency, and human oversight.

In 2025, Miracle helped biopharma teams gain real-time insight to run trials at scale.

The future of clinical trial oversight isn’t better alerts in one system; it’s alerts that reason across all of them.

This article introduces Miracle’s Real-Time Alerts, a new capability that gives clinical trial teams instant, customizable visibility across all their data, overcoming disconnected systems, static thresholds, and alert noise, to enable proactive, data-driven oversight and faster decision-making.

Jin Kim joins cc: Life Science to discuss how Miracle helps biotech teams accelerate clinical trials by turning siloed data into real-time operational insights, and why strong data infrastructure matters more than AI hype.

Faster trials, better outcomes: Key insights from the CMO Summit on accelerating clinical success.

Continuous data cleaning shortens data readout timelines and cuts costs for clinical trial sponsors.

Reflection on how Miracle has been empowering biotech clients on clinical trials.

Optimize enrollment closeout with data-driven strategies to minimize overshoot, reduce costs, and keep clinical trial timelines on track.